Table 4.

Rho Spearman coefficient is reported in the table. T0 = before GR administration; T1 = during GR administration; T2 = after GR administration; MA = more affected side; LA = less affected side; * = Correlation is significant at the 0.05 level; ** = Correlation is significant at the 0.01 level.

		T0		T1		T2
		Golden Ratio (MA)	Golden Ratio (LA)	Golden Ratio (MA)	Golden Ratio (LA)	Golden Ratio (MA)	Golden Ratio (LA)
Age		−0.529 *	−0.402	−0.529 *	−0.402	−0.404	−0.406
MDS-UPDRS		−0.213	−0.297	−0.213	−0.297	−0.373	−0.474 *
Disease duration		0.436	0.449 *	0.436	0.449 *	−0.006	0.207
Stride time	MA	−0.116	−0.332	−0.116	−0.332	−0.348	−0.233
	LA	−0.209	−0.305	−0.209	−0.305	−0.498 *	−0.214
Stance Percentage	MA	−0.825 **	−0.607 *	−0.825 **	−0.607 **	−0.998 **	−0.277
	LA	0.777 **	−0.868 **	−0.771 **	−0.868 **	−0.310	−0.995 **
Swing Percentage	MA	0.825 **	0.607 *	0.825 **	0.607 *	0.998 **	0.277
	LA	0.777 **	0.853 **	0.777 **	0.853 **	0.308	0.995 **
Double Support Time	MA	−0.663 **	−0.877 **	−0.663 **	−0.877 **	−0.487 *	−0.794 **
	LA	−0.540 *	−0.421	−0.540 *	−0.421	−0.720 **	−0.600 **
Step width		0.455 *	0.188	0.455 *	0.188	0.606 **	0.358
Stride length	MA	0.361	0.319	0.361	0.310	0.469 *	0.191
	LA	0.411	0.349	0.411	0.349	0.412	0.132
ϕ	MA	1	0.675 **	0.675 **	1	1	0.305
	LA	0.675 **	1	1	0.675 **	0.191	1
hMaxWrist	MA	−0.031	−0.468 *	−0.031	−0.468	0.229	−0.111
	LA	−0.027	−0.280	−0.026	−0.012	−0.053	0.072
Walking speed		0.324	0.364	0.324	0.364	0.564 **	0.275